These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

908 related items for PubMed ID: 18372433

  • 1. A randomized trial of iloprost in patients with intermittent claudication.
    Creager MA, Pande RL, Hiatt WR.
    Vasc Med; 2008 Feb; 13(1):5-13. PubMed ID: 18372433
    [Abstract] [Full Text] [Related]

  • 2. Cilostazol for intermittent claudication.
    Bedenis R, Stewart M, Cleanthis M, Robless P, Mikhailidis DP, Stansby G.
    Cochrane Database Syst Rev; 2014 Oct 31; 2014(10):CD003748. PubMed ID: 25358850
    [Abstract] [Full Text] [Related]

  • 3. Heparan sulfate in the treatment of intermittent claudication: results of a randomized, double-blind, placebo-controlled multicenter trial.
    Messa GL, Gelso E.
    Drugs Exp Clin Res; 2002 Oct 31; 28(1):37-48. PubMed ID: 12073766
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The influence of iloprost on blood rheology and tissue perfusion in patients with intermittent claudication.
    Ciuffetti G, Sokola E, Lombardini R, Pasqualini L, Pirro M, Mannarino E.
    Kardiol Pol; 2003 Sep 31; 59(9):197-204. PubMed ID: 14618196
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The novel phosphodiesterase inhibitor NM-702 improves claudication-limited exercise performance in patients with peripheral arterial disease.
    Brass EP, Anthony R, Cobb FR, Koda I, Jiao J, Hiatt WR.
    J Am Coll Cardiol; 2006 Dec 19; 48(12):2539-45. PubMed ID: 17174195
    [Abstract] [Full Text] [Related]

  • 8. Two randomised and placebo-controlled studies of an oral prostacyclin analogue (Iloprost) in severe leg ischaemia. The Oral Iloprost in severe Leg Ischaemia Study Group.
    Eur J Vasc Endovasc Surg; 2000 Oct 19; 20(4):358-62. PubMed ID: 11038148
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Anti-chlamydial antibiotic therapy for symptom improvement in peripheral artery disease: prospective evaluation of rifalazil effect on vascular symptoms of intermittent claudication and other endpoints in Chlamydia pneumoniae seropositive patients (PROVIDENCE-1).
    Jaff MR, Dale RA, Creager MA, Lipicky RJ, Constant J, Campbell LA, Hiatt WR.
    Circulation; 2009 Jan 27; 119(3):452-8. PubMed ID: 19139383
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Management of intermittent claudication with pentoxifylline: meta-analysis of randomized controlled trials.
    Hood SC, Moher D, Barber GG.
    CMAJ; 1996 Oct 15; 155(8):1053-9. PubMed ID: 8873633
    [Abstract] [Full Text] [Related]

  • 14. Rapid foot and calf compression increases walking distance in patients with intermittent claudication: results of a randomized study.
    Ramaswami G, D'Ayala M, Hollier LH, Deutsch R, McElhinney AJ.
    J Vasc Surg; 2005 May 15; 41(5):794-801. PubMed ID: 15886663
    [Abstract] [Full Text] [Related]

  • 15. [Microcirculation in peripheral arterial occlusive diseases will improve. Prostaglandin can prevent surgery].
    MMW Fortschr Med; 2003 Dec 18; 145(51-52):41. PubMed ID: 14974333
    [No Abstract] [Full Text] [Related]

  • 16. Acenocoumarol and pentoxifylline in intermittent claudication. A controlled clinical study. The APIC Study Group.
    Dettori AG, Pini M, Moratti A, Paolicelli M, Basevi P, Quintavalla R, Manotti C, Di Lecce C.
    Angiology; 1989 Apr 18; 40(4 Pt 1):237-48. PubMed ID: 2650578
    [Abstract] [Full Text] [Related]

  • 17. Treatment of severe intermittent claudication with pentoxifylline: a 40-week, controlled, randomized trial.
    Cesarone MR, Belcaro G, Nicolaides AN, Griffin M, De Sanctis MT, Incandela L, Geroulakos G, Ramaswami G, Cazaubon M, Barsotti A, Vasdekis S, Bavera P, Ippolito E.
    Angiology; 2002 Apr 18; 53 Suppl 1():S1-5. PubMed ID: 11865828
    [Abstract] [Full Text] [Related]

  • 18. Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication.
    Rajagopalan S, Mohler ER, Lederman RJ, Mendelsohn FO, Saucedo JF, Goldman CK, Blebea J, Macko J, Kessler PD, Rasmussen HS, Annex BH.
    Circulation; 2003 Oct 21; 108(16):1933-8. PubMed ID: 14504183
    [Abstract] [Full Text] [Related]

  • 19. Pentoxifylline--a new drug for the treatment of intermittent claudication.
    Chopra HK, Chopra KL, Aggarwal KK, Parashar SK.
    Indian Heart J; 1989 Oct 21; 41(2):127-33. PubMed ID: 2744799
    [Abstract] [Full Text] [Related]

  • 20. Pentoxifylline (Trental)--a new drug for the treatment of peripheral chronic occlusive arterial disease.
    Chopra HK, Chopra KL, Aggarwal KK, Parashar SK.
    J Med; 1988 Oct 21; 19(2):89-107. PubMed ID: 3049876
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.